Fisher & Paykel Healthcare Publishes CSR Report

Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)


FISHER & PAYKEL HEALTHCARE PUBLISHES CORPORATE RESPONSIBILITY AND
SUSTAINABILITY REPORT

Auckland, New Zealand, 8 November 2017 - Fisher & Paykel Healthcare has today published its
Corporate Responsibility and Sustainability Report for the financial year 1 April 2016 to 31 March
2017.

A copy is attached.

The report can also be viewed at www.fphcare.co.nz/sustainability

Investors:
Marcus Driller
General Manager Corporate
marcus.driller@fphcare.co.nz
+64 (0) 27 578 9963
Media:
Rachel Reynolds
Senior Communications Manager
rachel.reynolds@fphcare.co.nz
+64 (0) 21 713 911

Ends//

---

Corporate Responsibility and
Sustainability Report
For the year ended
31 March 2017
Innovation.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited1
Contents
MESSAGE FROM THE CEO
02
ABOUT US
04
ABOUT THIS REPORT
09
SUSTAINABILITY HIGHLIGHTS
11
BETTER CARE
12
EXCELLENT PEOPLE
14
SAFELY HOME
20
ENVIRONMENTAL CARE
23
STRONGER COMMUNITIES
30
Putting
people first.
We care for our patients, customers,
suppliers, shareholders, the
environment and each other and
are committed to improving care
and outcomes through inspired and
world-leading healthcare solutions.’
‘

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited2
Lewis Gradon
Managing Director and Chief Executive Officer
Message from the CEO
Our primary focus is in
ensuring we produce
innovative healthcare
devices that improve
the health and quality of
life for people all over
the world.’
‘

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited3
We contribute to furthering medical
knowledge by participating in clinical
research and changing clinical practice;
for example, there is a growing body of
clinical research showing the significant
improvements in medical outcomes
that can be achieved by use of our
Optiflow™ nasal high flow therapy.
We are a major employer, with our
own people in 35 countries around the
world. Due to our global reach, diversity
is part of our DNA. We endeavour to
always treat the people we employ, do
business with and who are otherwise
impacted by our work, with fairness
and respect.
This year we adopted a new Code of
Conduct. The Code covers areas such
as health and safety, diversity and
inclusion, responsible marketing
practices and guidelines for working
with customers, suppliers and
healthcare professionals. This Code
applies to all of our people globally,
with training conducted for New
Zealand employees, and is currently
being rolled out across our other
offices.
We have also developed a Supplier
Code of Conduct, which includes
information on human rights, labour
and employment, management systems
and data protection. Both of these
documents are available on our
company website at www.fphcare.co.
nz/corporategovernance
We see corporate social responsibility
and sustainability as inextricably linked
to the way we do business. We know
that strong financial performance
cannot be achieved without looking
after our people, suppliers and
customers. And being financially
successful means we can continue to be
a major contributor to medical care, to
our communities and economies
through areas such as tax and
employment, and to return a portion of
profits to our shareholders as dividends.
Our awareness of the reciprocal nature
of this is what we believe positions our
company for long-term, sustainable and
profitable growth.
We care for our patients, customers,
suppliers, shareholders, the
environment and each other and are
committed to improving care and
outcomes through inspired and
world-leading healthcare solutions.





LEWIS GRADON, MANAGING DIRECTOR
AND CHIEF EXECUTIVE OFFICER
PATIENTS TREATED DURING THE
YEAR USING OUR MEDICAL DEVICES
12M+
A MAJOR EMPLOYER, WITH PEOPLE
BASED IN 35 COUNTRIES
35
GROSS DIVIDENDS DISTRIBUTED TO
OUR SHAREHOLDERS DURING FY17
NZ
$153M
We are privileged to be in an industry where the work we do has a direct
impact on improving people’s lives, right around the world. Last year, we
estimate that our products were used in the treatment of over 12 million
patients. This means that our primary focus for sustainability is in ensuring
we produce innovative healthcare devices that improve the health and quality
of life for people all over the world.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited4
Fisher & Paykel Healthcare is a leading
designer, manufacturer and marketer
of products and systems for use in
respiratory care, acute care, surgery
and the treatment of obstructive sleep
apnea. The company’s world-leading
healthcare products are used to
improve health outcomes for millions
of patients every year.
Our medical devices and technologies
are designed to help patients get better
faster, which can then allow clinicians to
provide care for more patients.
We help patients transition to less acute
care settings, help them recover quicker
and provide solutions that can assist
them to avoid more acute conditions.
We also provide the ability for some
patients to be treated in the home
rather than the hospital. Our purpose is
to improve care and outcomes through
inspired and world-leading healthcare
solutions.
We manufacture, assemble and test our
range of products, including many
components, in our facilities in New
Zealand and Mexico. Our facilities
incorporate controlled working
environments and our manufacturing
and design processes are certified to
meet the international medical device
quality standard ISO13485.
Operating revenue for the company
was NZ$894 million for the 2017
financial year. We sell into over 120
countries and employ more than 4,000
people worldwide. We estimate that
during the year, over 12 million patients
were treated using our medical devices.
In September 2017 we were selected as
an index component of the Dow Jones
Sustainability Indices for the second
year running. This selection recognises
our corporate sustainability leadership
in the global healthcare equipment
industry. This year, we achieved a silver
recognition level in the EcoVadis
supplier CSR evaluation programme,
which places us within the top 30% of
respondents.
We are a member of the New Zealand
Sustainable Business Network and our
GM – Facilities and Environmental
Management is a member of the
Environmental Committee of Plastics
New Zealand. This year, we have
established a work plan to further
integrate social responsibility within
the company using the ISO26000
framework.
About Us

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited5
Our ValuesOur Beliefs
ORIGINALITY
We encourage original
thinking which leads to
the innovative solutions
required to create better
products, processes and
practices.
LIFE
We relentlessly focus
on improving patients’
lives and strive to
provide a high quality of
life for our employees.
RELATIONSHIPS
We care for our
patients, customers,
suppliers, shareholders,
the environment and
each other.
INTERNATIONALISM
We are global in
people, in thinking
and in behaviours.
COMMITMENT
We value people who
are self-motivated and
have a desire to make a
real contribution.
Our Purpose
Improving care and outcomes through inspired
and world-leading healthcare solutions.
We believe in
doing what is best
for the patient.
We believe our people
are our strength.
We believe the
commitment to doing
the right thing is what
our customers will find
compelling.
We believe lessons
learned are the
cornerstones of
innovation.
We believe that
empathy, effectiveness
and efficiency are
essential to our success.
We believe in the need
to be relentless in the
pursuit of healthcare
innovation.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited6
C
O
M
M
I
T
M
E
N
T






























O
R
I
G
I
N
A
L
I
T
Y






























R
E
L
A
T
I
O
N
S
H
I
P
S






























L
I
F
E






























I
N
T
E
R
N
A
T
I
O
N
A
L
I
S
M
a

s
u
s
t
a
i
n
a
b
l
e

w
a
y
E
n
s
u
r
e

o
u
r

g
r
o
w
t
h

i
s

m
a
n
a
g
e
d

i
n

S
u
s
t
a
i
n
a
b
l
e
,

p
r
o
fi
t
a
b
l
e

g
r
o
w
t
h
S
T
R
A
T
E
G
Y
C
o
n
t
i
n
u
o
u
s
l
y

s
t
r
i
v
e

t
o

i
m
p
r
o
v
e

o
u
r

p
r
o
d
u
c
t
s
B
e
t
t
e
r

p
r
o
d
u
c
t
s
S
T
R
A
T
E
G
Y
S
T
R
A
T
E
G
Y
C
h
a
n
g
e

c
l
i
n
i
c
a
l

p
r
a
c
t
i
c
e


U
t
i
l
i
s
e

o
u
r

e
x
p
e
r
t
i
s
e

t
o

d
e
v
e
l
o
p

n
e
w

t
h
e
r
a
p
i
e
s

a
n
d

r
e
d
u
c
e

c
o
s
t
s

t
o

h
e
a
l
t
h
c
a
r
e

s
y
s
t
e
m
s
S
T
R
A
T
E
G
Y
G
l
o
b
a
l

r
e
a
c
h


I
n
c
r
e
a
s
e

o
u
r

p
r
e
s
e
n
c
e

a
r
o
u
n
d

t
h
e

w
o
r
l
d
Our inputs
Our outputs
AGEING POPULATION | TECHNOLOGY ADVANCEMENT | HEALTHCARE COSTS INCREASING | OTHER EXTERNAL FACTORS
MARKET CONTEXT
Increased
efficiency
of care
Our
4000+ people
Improved
care &
outcomes for
patients
Over 45 years
of trusted
relationships
Benefits to
our people
Global
supply
networks
Increased
shareholder
value
Excellence
in R&D
Doubling
our constant
currency
revenue every
5-6 years
Trusted brand
Care by Design
Improving care & outcomes
through inspired and
world-leading healthcare
solutions
How we deliver value

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited7
Canada
Direct Sales
Distributed sales with FPH people
Distribution Centres
Manufacturing Facilities
Mexico
China
Hong Kong
Taiwan
Japan
South Korea
Portugal
Brazil
Saudi Arabia
Indonesia
Colombia
Spain
Wales
France
USA
India
AustraliaNew Zealand
Scotland
England
Sweden
Northern Ireland
Netherlands
Germany
Italy
Belgium
Finland
Austria
Ireland
Switzerland
Turkey
Russia
Norway
Denmark
35
Our people are located
in 35 countries
1,231
People in North America
271
People in Europe
2,307
People in New Zealand
303
People in the rest
of the world
Where we are in the world

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited8
Full Year Results
PROFIT AFTER TAX
NZ$169.2M
18%
OPERATING PROFIT
NZ$240.1M
14%
GROSS MARGIN IMPROVEMENT
205bps
HOSPITAL REVENUE GROWTH
NZ$500.4 MILLION
15%
NEW APPLICATIONS CONSUMABLES
REVENUE GROWTH
24%
OPERATING REVENUE
NZ$894.4 MILLION
10%
TOTAL DIVIDEND FOR THE YEAR
NZ 19.5CPS FULLY IMPUTED
17%
SPEND ON R&D
9.6% OF OPERATING REVENUE
NZ$86M

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited9
Unless otherwise stated, the metrics
provided in this report relate to the
financial year ended 31 March 2017
and apply to our New Zealand and
Mexico sites, which together account
for more than 70% of our people and
all of our manufacturing activity.
Financial data is in New Zealand
dollars, unless otherwise indicated.
The report’s purpose is to record some
of the progress made over this period
as we aim to improve our economic,
environmental and social performance
long-term.
This report is structured into the
following five sections which address
the areas of material opportunity and
risk for the company’s long term
sustainable operations:
About this report
BETTER CARE
We recognise that to continue to
fulfill our purpose we need to ensure
we produce new, innovative and high
quality healthcare devices that do a
better job of improving patient care
and outcomes.
EXCELLENT PEOPLE
Our ongoing success is a direct result
of the skills and expertise of our people.
Given the global competition for talent
we recognise the importance of
recruitment, training and retention
as well as diversity and inclusion.
SAFELY HOME
Ensuring all of our people make
it “safely home every day” is a priority.
ENVIRONMENTAL CARE
We recognise that the natural
environment is of essential value.
STRONGER COMMUNITIES
We strive to build and nurture strong,
lasting partnerships with local
communities and organisations relevant
to our company and people. This is
important to ensure a strong pipeline of
future employees, the engagement and
retention of our current employees and
a healthy community.
In 2015, the United Nations established the Sustainable Development Goals
(SDGs) to encourage action to improve people’s lives globally by building a
sustainable future for our people and our planet. The 17 goals encompass targets
that cover a broad range of sustainable development issues, such as ending
poverty and hunger, improving health and education, making cities more
sustainable and combating climate change.
We have taken inspiration from these goals, and have highlighted below the
SDGs to which we can contribute the most:
Better
Care
Excellent
People
Safely
Home
Environmental
Care
Stronger
Communities

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited10
FURTHER INFORMATION
To find out more about our approach to
sustainability, please visit www.fphcare.
co.nz/sustainability. Financial
performance for Fisher & Paykel
Healthcare can be found in the
company’s annual reports, available
online at www.fphcare.co.nz/investor.
Feedback on this sustainability report is
welcomed, and can be directed to
rachel.reynolds@fphcare.co.nz
The Board and management are
committed to ensuring that the
company adheres to best practice
governance principles and maintains
the highest ethical standards.
About this report (cont.)
The company publishes a separate
Corporate Governance Statement
containing its corporate governance
disclosures which is available online at:
www.fphcare.co.nz/
corporategovernance
KEY DOCUMENTS
Group Tax Strategywww.fphcare.co.nz/corporategovernance
Code of Conductwww.fphcare.co.nz/corporategovernance
Supplier Code of Conductwww.fphcare.co.nz/corporategovernance
Corporate Governance
Statementwww.fphcare.co.nz/investor/governance
Risk Management
www.fphcare.co.nz/corporategovernance
See also: 2017 Corporate Governance Statement pp. 5-6
Diversity Policywww.fphcare.co.nz/corporategovernance
Environmental Policywww.fphcare.co.nz/corporategovernance
ISO14001 certificationwww.fphcare.co.nz/sustainability
CEMARS certificationwww.fphcare.co.nz/sustainability
Carbon Disclosure
Project responsehttps://www.cdp.net/en/responses/6432

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited11
SUSTAINABILITY HIGHLIGHTS
ISO13485
RECERTIFICATION FOR
MANUFACTURING AND
DESIGN PROCESSES
SELECTED AS AN
INDEX COMPONENT
OF THE DOW JONES
SUSTAINABILITY
INDICES
CERTIFICATION TO NEW
ISO14001:2015 FOR OUR
NEW ZEALAND AND
MEXICO SITES
NEW SUPPLIER CODE OF
CONDUCT RELEASED
AVERAGE ANNUAL
TRAINING HOURS
(INTERNAL ONLY, PER
NZ AND MX EMPLOYEE):
25.2
REDUCTION IN CARBON
EMISSION INTENSITY:
22% OVER PAST FIVE
YEARS
REDUCTION IN
AIRFREIGHT
FROM 30+% TO <8%
RAINWATER
COLLECTED (FY17):
2,936M
3
AVERAGE HOURS
HEALTH & SAFETY
TRAINING PER
EMPLOYEE (NZ & MX):
1.5
GLOBAL LTIFR: 1.2

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited12
More clinicians are choosing to use our
products and technologies as clinical
evidence of the potential improvements
in effectiveness, efficiency and patient
outcomes grows. This has been an
important contributor to the increase in
the number of patients benefiting from
our products over the last year, which
we estimate was over 12 million.
Our manufacturing sites are certified to
the ISO 13485 Medical Devices – Quality
Management Systems standard, which
is provided through routine external
audits. Our products are thoroughly
tested to ensure a high degree of
quality before being released to the
market. Product inspections are
conducted either during production or
as a finished good by dedicated
inspection teams. Robust procedures
are in place to manage any product
recalls that may be required.
We are relentlessly committed to
product improvement, and this drives
our investment in innovation. In the
2017 financial year, we invested NZ$86
million into research and development,
which is approximately 10% of our
operating revenue.
The overarching principle of our
product innovation rests on doing what
is best for the patient.
Better Care
IN FY17, WE INVESTED
NZ$86 MILLION INTO R&D
NZ$86M
NUMBER OF PATIENTS BENEFITING
FROM OUR PRODUCTS IN FY17
12M+
We are focused on improving care
and outcomes through inspired
and world-leading healthcare
solutions. Our technologies are
aimed at increasing the
effectiveness and efficiency of
care, so patients can recover
quicker and if possible, be treated
in less acute areas of the hospital,
or in the home. With greater
demands being put on the world’s
healthcare systems by an ageing
population, this is becoming
increasingly important to
healthcare providers.
UN Sustainable
Development Goal

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited13
ADRIAN’S STORY
When Adrian and his wife, Bev, set out
to spend the weekend at their beach
house they had no idea what impact
the drive was to have on their lives.
Adrian fell asleep at the wheel twice
during the two-hour journey: the first
instance, he drove off the road into a
farmer’s fence; the second, his wife
told him to see his doctor.
For years, Adrian experienced “falling
asleep without knowing it” and also
“loud snoring”. His work colleagues
would laugh at him as he would fall
asleep at his desk. Adrian felt aware of
his colleagues around him but couldn’t
help drifting off to sleep. The tiredness
was something that developed slowly
for Adrian; he just assumed it was due
to his busy lifestyle. However, when his
wife and children started noticing his
snoring turn into jerking movements he
thought it could be something more
serious.
The accidents on the way to the beach
house were the “final straw” for Adrian
and his wife, so he organized a visit to
his doctor who told him to undergo a
sleep study. At the sleep lab Adrian was
told that he had obstructive sleep
apnea (OSA). Between falling asleep
and midnight he had unconsciously
stopped breathing over 300 times as
his airway was blocking. Adrian was
then prescribed continuous positive
airway pressure (CPAP) therapy by the
sleep technicians.
‘ Falling asleep at the
wheel with my wife in the
car was my wakeup call.’
Adrian immediately felt relieved that his
problem could be treated. The CPAP
machine took him a “week or so” to get
used to but now it has become a “very
important” part of his life. Adrian
described his brain as “raring to go
again”; he felt like he could concentrate
at work and his friends and family
commented that it’s great to see him
not falling asleep every few minutes.
Adrian’s advice for those thinking they
may have OSA is to go see a doctor and
if diagnosed, persevere with the
treatment. He says to “think positive
– anything you can do is worth it to
improve your life.”
‘ You can tell which
caravan is ours: you
can hear Dad snoring!’
Adrian Tidman

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited14
Our people are our strength. Our
ongoing success is a direct result of
their skills and expertise. We have
more than 4,000 people working in,
or supporting, over 120 countries
around the globe.
We value self-motivation, the drive to
make a real contribution and innovative
thinking. In return, we offer our people
the opportunity to work for a world
class, successful company where each
person is valued and respected. We
operate profit sharing bonus schemes
for all qualifying employees around the
world.
Fisher & Paykel Healthcare fully
supports the principles in the United
Nation’s Declaration on Human Rights
and the International Labour
Organisation Declaration on
Fundamental Principles and Rights at
Work, including non-discrimination,
freedom of association and collective
bargaining, and freedom from forced
and child labour. We seek to uphold
human rights in all business activities.
21% of our total number of global
employees are covered by collective
bargaining agreements. There is a
collective agreement in place for the
vast majority of our New Zealand-based
manufacturing employees.
Excellent People
UN Sustainable
Development Goal

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited15
RECRUITMENT AND
RETENTION
Worldwide, more than half of our
people are engaged in manufacturing
and operations roles, with the
remainder in sales, marketing,
distribution and product, clinical and
process development.
We operate employee health clinics and
confidential health assessments for
permanent and fixed term employees
when commencing employment at our
New Zealand and Mexico sites. This
enables a nurse and an employee to
meet and discuss any specific needs
relating to the employee’s ability to
perform their role.
A professional development
programme called Engage and Develop
runs in New Zealand, the US and Mexico
to assist in career planning and
progression.
We continue to develop and implement
a range of strategies to assist with:
»Attracting diverse talent into the
company
»Profiling our talent to ensure our
training and development initiatives
are targeted and in support of our
growth strategies
»Ensuring internal promotions are
made from a diverse pool of
appropriately qualified candidates
»Ensuring our pay practices are free
from any bias
»Creating deep talent pools to feed
our succession plans
Our employee turnover is typically
higher in Mexico than in most other
countries where we have employees.
Although our turnover rate in Mexico is
generally lower than comparable
companies with maquiladora
manufacturing facilities in Mexico, we
have made changes to our recruitment
practices, training initiatives and reward
systems which we believe will lower this
rate in future years, and have already
seen a reduction in Mexican employee
turnover in the last year.
FY13FY14FY15FY16FY17
11.2
10.0
9.3
9.6
8.2
Percent per year
FY13FY14FY15FY16FY17
22.2
20.3
16.7
25.6
21.0
Percent per year
NZ Employee
Turnover Rates
Rest of World Employee
Turnover Rates
FY13FY14FY15FY16FY17
12.3
13.5
11.7
14.6
13.9
Percent per year
Global Employee
Turnover Rates
Global Employee Turnover Rates

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited16
DIVERSITY AND
EQUAL EMPLOYMENT
Fisher & Paykel Healthcare and its
Board are committed to providing
equal employment opportunities and
as such, have a workforce consisting
of many individuals with diverse skills,
values, backgrounds, ethnicity and
experiences.
For us, a commitment to diversity
means ensuring that no individual is
excluded from a position, for which he
or she is skilled and qualified, by
inappropriate systems, practices and
attitudes. It also means eliminating
barriers to ensure that everyone is
considered for the employment of their
choice and that our people have the
chance to perform to their full potential.
We will ensure our selection processes
for recruitment and employee
development opportunities are free
from bias and are based on merit.
We have fostered a culture where
people are treated fairly and with
respect and we are committed to
ensuring an inclusive workplace.
We will:
»Promote awareness around the
importance of a diverse and inclusive
workforce;
»Encourage employees to offer views
and suggestions towards achieving
organisational goals;
»Review our systems, policies and
practices to make sure an inclusive
approach is taken; and
»Ensure our built environment
continues to support an inclusive
workplace.
As a global company, we value the
differences our people bring as we
believe this creates a diversity of
thinking that forms the foundations of
our culture. We believe that these
differences foster continuous
questioning and continuous
improvement which builds innovative
and high performing teams.
We strive to provide an environment
where all our people have the
opportunity to reach their full potential.
If we can achieve that, then we know
we are doing the best we can for not
only our people and our company, but
also for our patients and our
communities.
Our Code of Conduct states that no
person is excluded from a position for
which he or she is skilled and qualified,
by inappropriate systems, practices and
attitudes. We are a member of Diversity
Works in New Zealand, a national group
that supports organisations to promote
diversity and inclusion in their
businesses.
WomenMenWomen %Men %
Board1614%86%
Senior executives1614%86%
All employees1,5461,92445%55%
WomenMenWomen %Men %
Board1713%87%
Senior executives1811%89%
All employees1,8512,13546%54%
2016
2017
Our manufacturing sites pay above any
applicable minimum wage levels for our
employees. Duration of service,
development and training allow waged
employees to progress through
remuneration scales.
Our CEO and Vice President – Human
Resources are the company’s Diversity
Managers. The Remuneration and
Human Resources Committee is
responsible for overseeing the
company’s Diversity Policy. Each year
the Remuneration and Human
Resources Committee review and
report to the Board on the company’s
Diversity Policy, its diversity objectives
and the company’s achievement against
its diversity objectives, including the
representation of women at all levels of
the organisation.
The table below shows the respective
proportions of men and women on the
company’s Board, in senior executive
positions and across the whole
organisation as at 31 March 2016 and
31 March 2017. A ‘senior executive’ refers
to the Chief Executive Officer and
senior executives reporting directly to
the Chief Executive Officer.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited17
ETHICS
BUSINESS ETHICS
We adopted a new Code of Conduct in
January 2017. The Code sets out our
expectations for conducting business in
a legal, ethical and safe way. The Code
applies to all directors, executives,
employees and contractors of Fisher &
Paykel Healthcare globally. The Code
covers matters such as our commitment
to diversity, preventing harassment,
working safely, avoiding conflicts of
interest, competing fairly, environmental
responsibility and sustainability. Any
failure to comply with the Code is
treated seriously and may result in
disciplinary action.
We also have formal mechanisms in
place for employees to air grievances
and to file complaints without fear of
reprisal. The company has a
whistleblower policy, which provides
procedures and channels for disclosure
of serious wrongdoing. We respect and
support employees who in good faith
exercise their rights under this policy.
ANTI-BRIBERY AND
CORRUPTION
We do not tolerate bribery, corruption,
kickbacks or other types of improper
benefits, whether committed by our
own people or by anyone we deal with.
The Code sets out our expectations in
this regard.
In the course of our business we
interact with a wide range of
government officials and private sector
individuals or businesses, including
government regulators, inspection
authorities and healthcare professionals.
We follow all anti-bribery and
corruption laws in the countries in
which we operate and ensure our
activities do not improperly influence
the medical decisions of healthcare
professionals or the purchasing
decisions of entities that buy our
products.
Most of the countries in which we
operate have strict anti-bribery and
corruption laws. Failing to comply with
these laws could have serious
consequences for us, both as individuals
and as an organisation. In some cases,
these consequences could include
criminal charges.
The Code requires that where we
suspect bribery or corruption, either by
our own people or by any of our
suppliers, customers or other business
partners, we report it immediately.
As disclosed on 22 March 2017, a former
employee, Simon Hall, pleaded guilty to
charges laid by the Serious Fraud Office
(SFO), in relation to actions taken while
an employee of Fisher & Paykel
Healthcare. It is understood that Mr Hall
received approximately $213,000 in
payments. When the company became
aware in 2014 of issues relating to the
management of two Middle East
distributors, the company commissioned
a third party to conduct an internal
investigation. Following the outcome of
the investigation, Mr Hall was dismissed
for misconduct and the matter was
referred to the SFO. The company does
not tolerate this type of behaviour and,
following an independent review, we are
confident in our systems to prevent a
recurrence.
We never offer or accept (or ask a third
party to offer or accept) bribes,
facilitation payments, secret
commissions or kickbacks to or from
any person. These rules apply to all our
business activities, including any
interactions we may have with
government officials or with any private
person or business, either locally or
overseas.
INTERACTIONS WITH
HEALTHCARE PROFESSIONALS
The Code also requires us to comply
with internal policies which are
designed to ensure that our interactions
with healthcare professionals are
ethical, transparent and provide benefit
to patients. These interactions must not
have, or appear to have, an improper
influence on clinical judgement.
We often interact with healthcare
professionals in many different
countries. Collaborative relationships
with healthcare professionals are
important to us, and we are committed
to maintaining the highest standards of
integrity and transparency in all
interactions with them.
ANIMAL ETHICS
Regulatory bodies occasionally require
biocompatibility testing of our medical
device materials. This testing follows a
risk management approach based on
ISO 10993-1, Biological Evaluation of
Medical Devices. ISO 10993-1 includes
requirements for the wellbeing of
animals and for minimising the number
of animals involved, and tests are
conducted in laboratories accredited to
international standards (ISO 17025).
We may sometimes participate, observe
or otherwise be involved in clinical
studies which include animal testing.
We minimise this impact by ensuring
these activities are approved by the
relevant animal ethics committees and
comply with applicable legislation. We
support efforts to further reduce animal
testing by funding and supporting
research in sophisticated physiological
computer models.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited18
OUR PEOPLE IN
NORTH AMERICA
1,231
OUR PEOPLE IN
EUROPE
271
OUR PEOPLE IN
NEW ZEALAND
2,307
OUR PEOPLE IN THE REST
OF THE WORLD
303
TURNOVER RATE FOR
NEW ZEALAND EMPLOYEES
8.2%
HOURS SPENT ON EMPLOYEE INTERNAL
DEVELOPMENT TRAINING (NZ & MEXICO)
82,000+
OUR PEOPLE ARE LOCATED
IN 35 COUNTRIES
35
OUR PEOPLE SUPPORT
120 COUNTRIES
WE HAVE 17 DISTRIBUTION
CENTRES AROUND THE
WORLD
AT A GLANCE
FY15: 221
FY16: 258
FY15: 236
FY16: 265
FY15: 751
FY16: 922
FY15: 1,943
FY16: 2,142

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited19
How does Fisher & Paykel Healthcare
attract great talent?
Debra: Attracting great people is really
important to us. As our organisation
grows, we need to not only recruit
excellent people from outside the
organisation, but also be able to retain
and develop our people to meet future
critical functional and leadership roles.
In New Zealand, we work closely with
universities to attract graduates into our
roles, and we have also built proactive
relationships with schools in order to
support students into STEM* subjects.
More broadly, we also reach out to our
international networks and have
developed online tools to attract
employees. We have a strong
communications programme with
alumni and are able to provide a range
of international opportunities for our
people. And of course our efforts are
always measured so we can be sure
that what we’re doing is working.
How does the company help its
people develop and progress?
Debra: We are continually looking at
how we can develop our people. We
have support processes for succession
planning and also chess-boarding,
which helps us understand the
implications of one move on another.
This allows us to be deliberate in
providing opportunities for people to
develop the future skills they are going
to need, through initiatives such as job
enrichment and enlargement. We aim
to develop people through work
experience combined with coaching
and learning. It’s a very deliberate
approach. Dynamic systems and
processes are in place to help people
identify career opportunities and how
they can get there, and our leaders are
also trained to help people develop.
What are your goals for our people?
Debra: It’s important that we retain our
culture as we grow, such as our
innovation, commitment and
collaboration. We want to continue to
offer people fantastic development
opportunities within a wonderful
campus environment. This is a global
view: we have a unique Fisher & Paykel
Healthcare way that relates to all of our
offices around the world. We aim to
provide people with the opportunity to
do interesting, challenging and
motivating work in a positive
environment.

* Science, technology, engineering and
mathematics
Q+A WITH DEBRA LUMSDEN
Vice President - Human Resources
Q
Q
Q

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited20
Fisher & Paykel Healthcare is
committed to excellence in health and
safety and to maintaining a safe and
healthy workplace for our employees,
contractors, visitors and community.
As part of our global health and safety
plan, we are in the process of
implementing a global health and
safety reporting programme. This
system will enable all of our locations to
report health and safety incidents,
manage health and safety risks, and
provide data that will allow us to
identify and address trends, enable
internal and external benchmarking and
future proof the company’s expansion
from a health and safety perspective.
Our health and safety progress is
reported monthly to the Board of
Directors and to the Quality, Safety and
Regulatory Committee of the Board
three times a year.
Occupational health centres offer
services for New Zealand and Mexico
employees. Services vary, but in New
Zealand include, for example, a smoking
cessation programme, injury
management, rehabilitation and return
to work programmes, first aid,
emergency medical response
assistance, workplace assessments,
travel and influenza vaccinations, and
other targeted health and wellness
promotions.
Our Lost Time Injury Frequency Rate
(LTIFR) per million exposure hours at
our manufacturing sites was 2.77 in
FY14 and 2.97 in FY15. We now record
this number for all our global sites. In
FY16, it was 1.98 and in FY17 it was 1.22.
Our global total recordable injury
frequency rate (TRIFR) was 4.49 in FY16
and 2.57 in FY17.
In the 2017 financial year we
implemented regular health and safety
leadership walks for the executive team
on our New Zealand site. This initiative
helps us demonstrate the importance of
health and safety to the company.
Walks take place in manufacturing
areas, workshops, distribution centres
and other general areas.
Safely Home
»Fisher & Paykel Healthcare
is committed to providing
a workplace that minimises
health and safety risk to
our employees.
»Globally, employees are
required to acquaint themselves
with all applicable health and
safety policies of the company.
»The company has procedures
in place for the reporting of
health and safety incidents
at our sales, distribution
and manufacturing sites
around the world.
UN Sustainable
Development Goal

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited21

HEALTH & SAFETY
LEADERSHIP
»Leadership accountabilities
established with individual
performance reviews
»Reporting of Health &
Safety activities to a
subcommittee of our
Board of Directors
»Implemented Health &
Safety leadership walks
with the Executive
Leadership team
»Developed a global Health
& Safety policy
ENGAGEMENT

»Health & Safety Committee
under review to better align
with Health & Safety
direction.
»Health & Safety
improvements identified
and presented by
employees through weekly
road shows and show and
tell forums and monthly
Health & Safety Committee.
HAZARD
MANAGEMENT
FOCUS
»Focus on high risk within
the business
–Machine Safety
–Contractor Management
–Electrical Safety
–Chemicals
»Health and Occupational
Monitoring
–Noise
–Manual handling
–Chemicals
»Training our people
–Work at height
–Gantry operations
–Stress and fatigue
–Manual handling
»Reviewing and updating
health & safety policies
»Implementation of a new
global drug and alcohol
policy
LEARNING FROM
INCIDENTS AND
OTHERS
»Benchmarked our health
& safety performance
»Robust event
investigations to identify
root cause
»Safety Awareness Alerts –
shared learnings from
incidents
SYSTEMS AND
COMPLIANCE
»Health and safety audit of
Mexico site conducted by
the Directorate of Social
Welfare and Productivity.
Our Mexico site achieved a
score of 93% and is one of
170 companies
participating in this
programme across Mexico.
»New Zealand site
successfully completed the
ACC Workplace Safety
Management Practices and
Hazardous Substances
certification and retained
the top level of ‘Tertiary’.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited22
AVERAGE HOURS OF HEALTH & SAFETY TRAINING
PER EMPLOYEE (NZ AND MX)
1.5 PER PERSON
At a glance
Global LTIFR
FY15*FY16FY17
2.97
1.98
1.22
Per million hours worked
* (NOT RECORDED)
* NZ AND MX ONLY
Global TRIFR
FY15*FY16FY17
4.49
2.57
Per million hours worked

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited23
Fisher & Paykel Healthcare recognises
that the natural environment is of
essential value. To reflect our
commitment, the company is
dedicated to implementing sustainable
business practices and maintaining an
on-going carbon emission
measurement and reporting scheme.
Carbon emission reduction
management projects are monitored
quarterly and reported annually within
the Group Facilities and Environmental
Business Plan, which is presented to
senior management and approved by
the company’s Board of Directors.
We participate in the Carbon Disclosure
Project, which requires us to report on
estimated greenhouse gas emissions,
energy use and the risks and
opportunities from climate change. In
the most recent reporting period, we
achieved a Carbon Disclosure Project
score of B, an increase from C in FY16.
This is ‘management’ level, and is
awarded for evidence of actions
associated with good environmental
management.
A large portion of our products are
consumable in nature to avoid
cross-infection between patients when
used in a hospital setting. Once these
consumable products have been used
in the hospital, they are classified as
medical waste and must be disposed of
in accordance with country-specific
waste guidelines and regulations. We
have begun exploring how we can
support our customers to reduce the
impact on the environment associated
with the disposal of end of life products.
Our approach to sustainability is to
measure or estimate current use
across a range of parameters, and
to put strategies in place to improve
our performance.
Over the past few years, our initiatives
have driven significant improvements in
manufacturing sustainability, carbon
management, waste and energy
management and water use.
Environmental Care
UN Sustainable
Development Goal

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited24
CARBON EMISSIONS
Fisher & Paykel Healthcare is committed
to reducing carbon emission intensity.
We have developed a Greenhouse Gas
Emissions Management Plan and
reduction targets, and have been
reporting our estimated emissions
under the Certified Emissions
Measurement and Reduction Scheme
(CEMARS) since 2012/13.
Over the five years since we started
reporting under the CEMARS
programme, we have achieved a 22%
reduction in reported emission intensity
and are on track to meet the targets set
out in our Emissions Reductions Plan.
Operational emissions intensity,
expressed in tCO
2
e/NZ$M, relates to
our New Zealand and Mexico
manufacturing facilities, as well as our
US, Australia, Germany, France and UK
distribution centres and our sales
operations in India, China, Japan,
Canada and Hong Kong. Freight
emissions decreased during FY17 due to
planning practices which saw
preference of sea freight over air freight.
Our revenue is generated in a range of
currencies, including US dollars and
Euros. As a result, fluctuations in
exchange rates can influence the
emission intensity calculation.
tCO
2
e/NZ$M
FY13FY14FY15FY16FY17
46.61
36.65
30.88
38.76
9.71
5.86
31.24
8.82
6.33
9.69
5.89
9.60
7.56
11.05
3.91
70
60
50
40
30
20
10
0
Freight
Electricity
Air Travel
Total
CARBON EMISSION INTENSITY
Carbon emission intensity target of 5% reduction pa.
MANUFACTURING
SUSTAINABILITY
We are striving to achieve operational
excellence through a commitment to
lean manufacturing. One of our key
initiatives is a mature and ongoing
Kaizen culture.
The Kaizen process is about making
small, regular improvements in the
way we work, which over time add
up to significant change. The process
is aligned with continuous improvement
philosophies which supports both
business growth and each individual’s
development within Fisher & Paykel
Healthcare.
Our approach to Kaizen covers the six
areas of safety, quality, delivery, cost,
people and environment. Progress is
monitored monthly against four key
metrics: suggestions per employee,
implementation trends, conversion
ratio, and participation level.
We have found that Kaizen promotes
motivation and engagement in our
employees as we collectively strive for
continuous improvement. We support
this with a tiered recognition process,
where the most innovative
improvements are shared with peers
and recognised by the company’s
executive management team and Board.
Kaizen is a way of life for us on our
manufacturing sites.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited25
WASTE
We have a target of recycling 96%
of our waste. In FY17, our waste to
landfill from our NZ site increased
by 63 tonnes due to continued
disruption in recycling service
provision and improvement of our
reporting methods. Procedures
have now been put in place to
address this and we expect to
optimise our recycling system in
FY18.
We run an active eco-efficiency
recycling programme in New
Zealand and Mexico. This
programme enables us to recycle
up to 100 tonnes of material a
month and includes set targets and
detailed plans to design out waste
from our operations. This
programme is shared during new
employee inductions, and we also
actively engage with suppliers to
support this initiative.
This financial year we measured
waste outputs in China, Hong Kong
and the UK for the first time. The
data from these regions, combined
with New Zealand, Australia and
Mexico, equates to 0.33 tCO
2
e/
NZ$M. This accounts for 0.85% of
our global emissions intensity.
ENERGY USE
Emission intensity from
electricity used at our New
Zealand and Mexico sites
reduced by 9% over the past
financial year. This was a result of
ongoing energy reduction
projects such as the installation
of LED lighting and other
process improvements. Emission
intensity resulting from
electricity use in the UK, US,
Australia, France, Germany,
Japan, India, China, Hong Kong
and Canada was also calculated
for FY17 and accounted for a
combined 0.61 tCO
2
e/NZ$M
(1.3% of total emission intensity).
Freight accounted for 65% of the
global business emissions
intensity.
WATER
Our most recently constructed
building is located in Auckland,
New Zealand, and operates a
rainwater collection system
where rainwater is recycled for
toilet flushing, which minimises
water usage. 2936m3 of
rainwater was collected and
utilised in this building.
STORM WATER
MANAGEMENT
Our Auckland facilities have a
campus-style layout, with storm
water from the site diverted into
a multi-staged sedimentation
pond. Besides acting as a scenic
centrepiece to the campus, the
pond minimises our impact on
downstream water quality by
allowing sediment to settle prior
to discharge into the nearby
Tamaki River.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited26
This year we ran several environmental
initiatives. In New Zealand, we
partnered with Ecoware, a carboNZero
certified packaging company, to
supply employees with compostable
coffee cups that are made from plant
material, rather than polystyrene.
Within the first month, we were able to
increase our volume of organic waste
from an average of 3.6 tonnes to 5.5
tonnes, the equivalent of diverting
62,500 polystyrene cups from landfill.
Supported by an internal
communications campaign, we now
collect around 7.2 tonnes of
compostable waste each month.
Other exciting environmental initiatives
include the installation of four electric
vehicle charging stations in the
company car park (Auckland site),
battery recycling programmes,
improved waste sorting and recycling
signage, tree planting days in Auckland
and beach clean ups in Tijuana.
GREENING OUR CAMPUSES

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited27
SUPPLY CHAIN AND SUSTAINABLE PROCUREMENT
Fisher & Paykel Healthcare’s supply
chain comprises a network of
suppliers, manufacturing sites and
distribution centres strategically
located around the globe to increase
responsiveness, reduce risk and ensure
consistent and optimal delivery to
both internal and external customers.
At the heart of our supply chain
operations is the enterprise resource
planning (ERP) system, supported by
our internal quality management
system and internal analytics and
solutions division.
We are committed to building a supply
chain structure that supports the
business’ approach to corporate social
responsibility and sustainability. We
strive to establish our company values
and beliefs across the supply chain and
have implemented policies that drive
our purchasing decisions to consider a
holistic approach across economic,
environmental and social aspects.
We are committed to influencing our
existing supplier base to maintain our
high quality standards and encourage
sustainable business practice across the
value chain.
We are developing our internal
framework and systems in collaboration
with our suppliers to perform a gap
assessment and achieve our goal of
implementing ISO 20400 sustainable
procurement guidance within our
supply chain.
Our procurement and sourcing staff are
based in New Zealand, Mexico and
Hong Kong. Utilising our quality
management system and category
management programmes, the teams
work to reduce supplier risk through
creating an environment of
transparency. They also focus on
partnering with suppliers that can
support our growth and are committed
to sustainable practices.
Our planning and manufacturing
operations are based in Mexico and
New Zealand. This means we are able
to manufacture and dual source our
supply and delivery to customers. In
order to support the 120 countries that
we deliver to, we use a combination of
Fisher & Paykel Healthcare operated
distribution centres and third party
distributors.
OUR APPROACH
We partner with over 2,200 suppliers
based in more than 36 countries.
We practise a category management
philosophy and have grouped our
global spend by the following areas
across 30 different categories:
»Supply chain materials and products
»Research and development
»Commercial service
GLOBAL SPEND BY REGION FY17
North America
Asia
Europe/Rest of World
NZ/Oceania
3
0%
4%
57%
9%

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited28
SUSTAINABILITY RISK
ASSESSMENT PROCESS
This year, we completed a global
sustainability risk assessment based on
our knowledge and understanding of
sustainability impacts related to the
categories we source, our supply chains
and sourcing countries.
We apply our Value Chain Risk
Assessment filters to any suppliers
that are identified within the high risk
category. These filters assist us to
consider the impact on our business
based on our category management
plan and is audited from a sustainability
risk perspective.
In the next financial year, we intend to
continue to develop a framework to
meet ISO 20400 standards, integrate
quality management audits with
sustainability audits, and provide
further guidance to our small and
medium enterprise vendors.
Low
Risk
Med
Risk
High
Risk
69%
30%
2%
SUSTAINABILITY & VALUE CHAIN
RISK ASSESSMENT ACROSS OUR
GLOBAL SUPPLIERS (FY17)
Percentage of suppliers scoring low,
medium and high risk.
Sustainability Risk
Assessment by category
Continue to
Monitor
Low Risk
Med Risk
Value Chain Risk Assessment
Is the Risk
High?
YES
NO
High Risk
Supplier Audits &
Corrective Plans

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited29
»Completed social and ethical benchmarking report
»Completed risk assessment across all categories for sustainability and
business risk
»Sustainable procurement practices implemented during vendor selections
process
»Continued with the global roll out of our new ERP system including
advanced supply chain modules:
–Advanced planning optimiser
–Extended warehouse management
»Development and release of Supplier Code of Conduct
»Development of supplier risk management process
»Development of product portfolio prioritisation (ABC) process
»Reduction in air freight from 30+% to <8%
»Consistently delivering +95% service level
»Opening of new export global distribution centre in California, USA.
»Selection and implementation of new UK distribution facility
»Certification to new ISO14001:2015 environmental management standard
for both New Zealand and Mexico sites.
KEY ACHIEVEMENTSAT A GLANCE
96%
9%
2,936m
3

86%
3%22%
OPERATIONAL WASTE RECYCLING
EMISSION INTENSITY
RAINWATER COLLECTED
Target
Reduction in
electricity emission
intensity globally
Progress
Reduction in electricity
consumption at NZ
facility
Reduction in total
emission intensity
over past 5 years
Certifications: ISO 14001:2015
(New Zealand and Mexico sites)

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited30
We seek to build and nurture strong,
lasting partnerships with local
communities and organisations relevant
to our company and people.
Through a combination of financial and
in-kind support, we have implemented
and sponsored various community
development programmes, particularly
in the areas of science and technology.
As we continue to grow, our capacity to
expand and enhance these important
programmes will also increase.
We provide financial sponsorship of
the Auckland-based Middlemore
Foundation, Auckland City Hospital,
and the Intensive Care Foundation in
Australia. Each year, we employ a large
number of university students at our
New Zealand manufacturing and
R&D site.
We run a comprehensive programme
of educational events, where we visit
local schools and universities to discuss
career pathways in STEM. We also
sponsor a range of events and
organisations in the science and
engineering fields. In the 2017
financial year, these included ‘She
Sharp’, which encourages women to
take up careers in ICT and other
tech-related fields, ‘Future in Tech’,
where we provided 13 ambassadors to
help run visits to local schools to talk
about STEM* careers, and ‘South Sci’,
mentoring of students undertaking
scientific projects in local schools. In
2016, we supported one of our
engineers through the ‘Engineers
without Borders’ programme.
In the 2017 financial year, we made
donations of NZ$57k to not for profit
organisations. We have a stance of only
supporting non-political groups.
We are listed on the New Zealand and
Australian stock exchanges. We value
the support and confidence of our
shareholders and our Board seeks to
achieve the highest standards of
corporate governance and investor
relations best practice. We return a
large proportion of our profit to
shareholders as dividends. Over the
past five years, this has totalled more
than NZ$400M.
The company has also recently
established a dedicated corporate
social responsibility (CSR) group, which
promotes and assists in the
coordination of CSR initiatives across
the company.
Clinical studies are an important
element in building confidence in the
efficacy of our products, particularly in
new clinical settings. We support clinical
research that validates improvements in
patient outcomes that our products can
deliver, and we work closely with
clinicians and healthcare organisations
to support these studies and identify
ways in which our products can help
them provide better healthcare
solutions.
*Science, Technology, Engineering, Mathematics
Stronger Communities
GROSS DIVIDENDS DISTRIBUTED
SINCE FY13
IN NEW ZEALAND, COLLECTED
AND PAID TAXES OF APPROX.
NUMBER OF PATIENTS TREATED
BY OUR DEVICES IN FY17
12M+
At a glance
Our primary contribution to the community is in the nature of the work that
we do – as a medical device designer, manufacturer and marketer, we employ
an increasing number of people who work to provide innovative technologies
that help improve care and outcomes around the world. With the number of
patients treated by our devices estimated to be over 12 million and growing
every year, and more than 4,000 people employed, the impact on our
communities is considerable.
NZ
$400M+
NZ
$110M
UN Sustainable
Development Goal

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited31
SUSTAINABLE TAX
STRATEGY
Fisher & Paykel Healthcare
understands that collecting
and paying tax is an important
contribution to the economies,
societies and communities in
which we operate. In support of
our overall business strategy and
objectives, we pursue a tax strategy
that is principled, transparent and
sustainable in the long term.
Fisher & Paykel Healthcare makes a
valuable contribution to the economies
in which we operate through payment
of corporate income taxes and remitting
employment related taxes on behalf
of our employees. We support the
OECD Business and Industry Advisory
Committee (BIAC) Statement of Tax
Principles for International Business and
have endorsed these principles in our
published Group Tax Strategy which
was reviewed and approved by our
Board in November 2016.
Our tax strategy sets out our approach
to tax governance and tax management
aligned to our conservative appetite for
tax risk with the key purposes to ensure
that we comply with all of our tax
obligations, undertake all transactions
with a business purpose considering all
of our stakeholders and have an open
and transparent relationship with the
tax authorities.
The majority of our taxes are paid in
New Zealand to the Inland Revenue
Department. This is in line with Fisher
& Paykel Healthcare’s business model
where the majority of manufacturing
and R&D is performed in New Zealand
and the majority of intellectual property
is owned in New Zealand.

Corporate Responsibility and Sustainability Report 2017Fisher & Paykel Healthcare Corporation Limited32
Fisher & Paykel Healthcare has come
together with clinicians in a joint
effort to raise funds for Lifebox, which
supports safer healthcare in
developing countries.
Lifebox is a non-government
organisation dedicated to safer surgery
and anaesthesia in low-resource
settings and is closely associated with
the Association of Anaesthetists for
Great Britain and Ireland (AAGBI). It
links professional, academic and
commercial organisations in order to
supply pulse oximeters into operating
theatres in developing countries and a
Surgical Safety Checklist education
programme for clinicians.
Pulse oximeters are monitors that clip
onto a patient’s finger and track their
oxygen level, and are recognised as a
key safety tool during surgery. Patients
who are left unmonitored can
experience cardic arrest from an
undiagnosed lack of oxygen.
Comprising a joint team of Fisher &
Paykel Healthcare team members and
AAGBI members, the charity cycle ride
took place from Fisher & Paykel
Healthcare’s UK office in Maidenhead to
the CARE airway and respiratory
convention at Warwick University in
June 2017, raising funds for Lifebox.
The team of 15 took two days to
complete the 220km journey.
“The trip took us through the beautiful
but hilly Cotswolds. It was a challenging
ride and the first long cycle for many of
us,” said Sophie Danks, Fisher & Paykel
Healthcare Sales Manager, “But being
able to support Lifebox in this way was
something we’re very proud of and
fortunate to do.”
HOW PEDAL POWER IS HELPING
TO MAKE SURGERY SAFER
This is the second charity cycle the
team has been involved in, after cycling
from Maidenhead to Paris in 2016 in
support of BirthLink, a charity working
to improve maternal and neonatal care
in developing countries.

Fisher & Paykel Healthcare is a world leader in
medical devices and systems for use in respiratory
care, acute care, surgery and in the treatment of
obstructive sleep apnea.
www.fphcare.co.nz/sustainability
© 2017 Fisher & Paykel
Healthcare Corporation Limited